Equillium (EQ) Profit After Tax (2018 - 2026)
Equillium (EQ) reported Profit After Tax of -$5.3 million for Q1 2026, up 38.63% year-over-year from -$3.8 million in Q1 2025, and down 40.69% quarter-over-quarter from -$3.8 million in Q4 2025.
Equillium (EQ) Profit After Tax (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Profit After Tax data on file, last reported at -$5.3 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$5.3 million, up 38.63% year-over-year; the trailing twelve-month figure through Mar 2026 was -$19.1 million (down 36.23% YoY), and the FY2025 annual result was -$22.4 million, down 177.65% from the prior year.
- Profit After Tax eased to -$5.3 million in Q1 2026 per EQ's latest filing, from -$3.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at $2.8 million in Q4 2022 and troughed at -$37.4 million in Q1 2022.
- A 5-year average of -$6.6 million and a median of -$3.9 million in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax surged 126.11% in 2022, then plunged 60328.57% in 2025.
- A 5-year view of Profit After Tax shows it stood at $2.8 million in 2022, then slumped by 184.46% to -$2.3 million in 2023, then tumbled by 147.4% to -$5.8 million in 2024, then surged by 34.85% to -$3.8 million in 2025, then slumped by 40.69% to -$5.3 million in 2026.
- Business Quant data shows EQ's Profit After Tax at -$5.3 million in Q1 2026, -$3.8 million in Q4 2025, and -$4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | -5.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.31 Mn |
| Dec 31, 2025 | -3.78 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Jun 30, 2025 | -5.74 Mn |
| Mar 31, 2025 | -8.65 Mn |
| Dec 31, 2024 | -5.79 Mn |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | 468,000.00 |
| Mar 31, 2024 | -2.73 Mn |
| Dec 31, 2023 | -2.34 Mn |
| Sep 30, 2023 | -3.71 Mn |
| Jun 30, 2023 | -3.34 Mn |
| Mar 31, 2023 | -3.94 Mn |
| Dec 31, 2022 | 2.77 Mn |
| Sep 30, 2022 | -13.66 Mn |
| Jun 30, 2022 | -14.13 Mn |
| Mar 31, 2022 | -37.42 Mn |
| Dec 31, 2021 | -10.62 Mn |
| Sep 30, 2021 | -10.28 Mn |
| Jun 30, 2021 | -9.16 Mn |